Tongyu J. Lin

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial.

Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial.

Journal: Journal for immunotherapy of cancer

Published: March 30, 2026

Identification of disulfidptosis-related molecular subtypes in pleural mesothelioma demonstrates a correlation with the immune infiltration, prognosis and therapy efficacy.

Identification of disulfidptosis-related molecular subtypes in pleural mesothelioma demonstrates a correlation with the immune infiltration, prognosis and therapy efficacy.

Journal: Discover oncology

Published: March 13, 2026

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

Journal: Blood cancer journal

Published: October 31, 2025

Interpretation of the "Guidelines for public health adaptation actions to climate change"

Interpretation of the "Guidelines for public health adaptation actions to climate change"

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: October 23, 2025

Dynamic monitoring of circulating cell-free EBV-DNA for risk assessment in early-stage natural killer/T-cell lymphoma.

Dynamic monitoring of circulating cell-free EBV-DNA for risk assessment in early-stage natural killer/T-cell lymphoma.

Journal: Blood advances

Published: October 22, 2025

Dynamic monitoring of circulating cell-free EBV-DNA for risk assessment in early-stage natural killer/T-cell lymphoma.

Dynamic monitoring of circulating cell-free EBV-DNA for risk assessment in early-stage natural killer/T-cell lymphoma.

Journal: Blood advances

Published: October 22, 2025

6-month Progression-Free Survival (PFS6) as a prognostic factor in large B-cell lymphoma patients undergoing chimeric antigen receptor T-cell therapy: A real-world multicenter study.

6-month Progression-Free Survival (PFS6) as a prognostic factor in large B-cell lymphoma patients undergoing chimeric antigen receptor T-cell therapy: A real-world multicenter study.

Journal: Annals of hematology

Published: September 03, 2025

Targeting cancer-induced nerve injury reverses immunotherapy resistance.

Targeting cancer-induced nerve injury reverses immunotherapy resistance.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 02, 2025

A novel prognostic model based on CA stage for enhanced stratification and survival prediction in patients with Natural killer/T-cell lymphoma.

A novel prognostic model based on CA stage for enhanced stratification and survival prediction in patients with Natural killer/T-cell lymphoma.

Journal: Annals of hematology

Published: August 04, 2025

Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review).

Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review).

Journal: International journal of oncology

Published: July 08, 2025

ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: June 12, 2025

Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphoma.

Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphoma.

Journal: Frontiers in nutrition

Published: May 04, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026